Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

The month of September was broadly focused on high inflation rates, rising interest rates and increasing concerns over the geopolitical situation including energy. The Nasdaq Biotech Index was down by 2.4% (in USD) in September, BB Biotech´s Net Asset Value was down by 2.7% (in USD) and the share price decreased by 7.1% (in CHF) in the same period.

BB Biotech Update September 2022

The month of September was broadly focused on high inflation rates, rising interest rates and increasing concerns over the geopolitical situation including energy. The Nasdaq Biotech Index was down by 2.4% (in USD) in September, BB Biotech´s Net Asset Value was down by 2.7% (in USD) and the share price decreased by 7.1% (in CHF) in the same period.
10.10.2022 - BB Biotech